Global Pharmaceutical Dissolution Testing Services Market Research Report 2024

Publication ID:

PB506248511

Publication Date:

June 21, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Due to increased R&D expenditure by pharmaceutical companies as well as an increase in the number of novel medications entering the preclinical stage of development, there has also been an increase in demand for pharmaceutical dissolution testing services.The dissolution testing services were initially disturbed due to the pandemic.
The global Pharmaceutical Dissolution Testing Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Dissolution Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Dissolution Testing Services.
Report Scope
The Pharmaceutical Dissolution Testing Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Dissolution Testing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Dissolution Testing Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Intertek Group Plc.
Avivia BV
Almac Group
Agilent Technologies, Inc.
Catalent, Inc.
Thermofisher Scientific Inc.
Cambrex
Charles River Laboratories
Boston Analytical
Pace Analytical Life Sciences
SOTAX
AMRI
SGS SA
Segment by Type
In vitro
In vivo
Segment by Application
Capsules
Tablets
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Dissolution Testing Services companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Dissolution Testing Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 In vitro
1.2.3 In vivo
1.3 Market by Application
1.3.1 Global Pharmaceutical Dissolution Testing Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Capsules
1.3.3 Tablets
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Dissolution Testing Services Market Perspective (2019-2030)
2.2 Pharmaceutical Dissolution Testing Services Growth Trends by Region
2.2.1 Global Pharmaceutical Dissolution Testing Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical Dissolution Testing Services Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical Dissolution Testing Services Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical Dissolution Testing Services Market Dynamics
2.3.1 Pharmaceutical Dissolution Testing Services Industry Trends
2.3.2 Pharmaceutical Dissolution Testing Services Market Drivers
2.3.3 Pharmaceutical Dissolution Testing Services Market Challenges
2.3.4 Pharmaceutical Dissolution Testing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Dissolution Testing Services Players by Revenue
3.1.1 Global Top Pharmaceutical Dissolution Testing Services Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical Dissolution Testing Services Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Dissolution Testing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Dissolution Testing Services Revenue
3.4 Global Pharmaceutical Dissolution Testing Services Market Concentration Ratio
3.4.1 Global Pharmaceutical Dissolution Testing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Dissolution Testing Services Revenue in 2023
3.5 Pharmaceutical Dissolution Testing Services Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Dissolution Testing Services Product Solution and Service
3.7 Date of Enter into Pharmaceutical Dissolution Testing Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Dissolution Testing Services Breakdown Data by Type
4.1 Global Pharmaceutical Dissolution Testing Services Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical Dissolution Testing Services Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical Dissolution Testing Services Breakdown Data by Application
5.1 Global Pharmaceutical Dissolution Testing Services Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical Dissolution Testing Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Dissolution Testing Services Market Size (2019-2030)
6.2 North America Pharmaceutical Dissolution Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical Dissolution Testing Services Market Size by Country (2019-2024)
6.4 North America Pharmaceutical Dissolution Testing Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Dissolution Testing Services Market Size (2019-2030)
7.2 Europe Pharmaceutical Dissolution Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical Dissolution Testing Services Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical Dissolution Testing Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Dissolution Testing Services Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical Dissolution Testing Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical Dissolution Testing Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical Dissolution Testing Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Dissolution Testing Services Market Size (2019-2030)
9.2 Latin America Pharmaceutical Dissolution Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical Dissolution Testing Services Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical Dissolution Testing Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Dissolution Testing Services Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical Dissolution Testing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical Dissolution Testing Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical Dissolution Testing Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Intertek Group Plc.
11.1.1 Intertek Group Plc. Company Detail
11.1.2 Intertek Group Plc. Business Overview
11.1.3 Intertek Group Plc. Pharmaceutical Dissolution Testing Services Introduction
11.1.4 Intertek Group Plc. Revenue in Pharmaceutical Dissolution Testing Services Business (2019-2024)
11.1.5 Intertek Group Plc. Recent Development
11.2 Avivia BV
11.2.1 Avivia BV Company Detail
11.2.2 Avivia BV Business Overview
11.2.3 Avivia BV Pharmaceutical Dissolution Testing Services Introduction
11.2.4 Avivia BV Revenue in Pharmaceutical Dissolution Testing Services Business (2019-2024)
11.2.5 Avivia BV Recent Development
11.3 Almac Group
11.3.1 Almac Group Company Detail
11.3.2 Almac Group Business Overview
11.3.3 Almac Group Pharmaceutical Dissolution Testing Services Introduction
11.3.4 Almac Group Revenue in Pharmaceutical Dissolution Testing Services Business (2019-2024)
11.3.5 Almac Group Recent Development
11.4 Agilent Technologies, Inc.
11.4.1 Agilent Technologies, Inc. Company Detail
11.4.2 Agilent Technologies, Inc. Business Overview
11.4.3 Agilent Technologies, Inc. Pharmaceutical Dissolution Testing Services Introduction
11.4.4 Agilent Technologies, Inc. Revenue in Pharmaceutical Dissolution Testing Services Business (2019-2024)
11.4.5 Agilent Technologies, Inc. Recent Development
11.5 Catalent, Inc.
11.5.1 Catalent, Inc. Company Detail
11.5.2 Catalent, Inc. Business Overview
11.5.3 Catalent, Inc. Pharmaceutical Dissolution Testing Services Introduction
11.5.4 Catalent, Inc. Revenue in Pharmaceutical Dissolution Testing Services Business (2019-2024)
11.5.5 Catalent, Inc. Recent Development
11.6 Thermofisher Scientific Inc.
11.6.1 Thermofisher Scientific Inc. Company Detail
11.6.2 Thermofisher Scientific Inc. Business Overview
11.6.3 Thermofisher Scientific Inc. Pharmaceutical Dissolution Testing Services Introduction
11.6.4 Thermofisher Scientific Inc. Revenue in Pharmaceutical Dissolution Testing Services Business (2019-2024)
11.6.5 Thermofisher Scientific Inc. Recent Development
11.7 Cambrex
11.7.1 Cambrex Company Detail
11.7.2 Cambrex Business Overview
11.7.3 Cambrex Pharmaceutical Dissolution Testing Services Introduction
11.7.4 Cambrex Revenue in Pharmaceutical Dissolution Testing Services Business (2019-2024)
11.7.5 Cambrex Recent Development
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Detail
11.8.2 Charles River Laboratories Business Overview
11.8.3 Charles River Laboratories Pharmaceutical Dissolution Testing Services Introduction
11.8.4 Charles River Laboratories Revenue in Pharmaceutical Dissolution Testing Services Business (2019-2024)
11.8.5 Charles River Laboratories Recent Development
11.9 Boston Analytical
11.9.1 Boston Analytical Company Detail
11.9.2 Boston Analytical Business Overview
11.9.3 Boston Analytical Pharmaceutical Dissolution Testing Services Introduction
11.9.4 Boston Analytical Revenue in Pharmaceutical Dissolution Testing Services Business (2019-2024)
11.9.5 Boston Analytical Recent Development
11.10 Pace Analytical Life Sciences
11.10.1 Pace Analytical Life Sciences Company Detail
11.10.2 Pace Analytical Life Sciences Business Overview
11.10.3 Pace Analytical Life Sciences Pharmaceutical Dissolution Testing Services Introduction
11.10.4 Pace Analytical Life Sciences Revenue in Pharmaceutical Dissolution Testing Services Business (2019-2024)
11.10.5 Pace Analytical Life Sciences Recent Development
11.11 SOTAX
11.11.1 SOTAX Company Detail
11.11.2 SOTAX Business Overview
11.11.3 SOTAX Pharmaceutical Dissolution Testing Services Introduction
11.11.4 SOTAX Revenue in Pharmaceutical Dissolution Testing Services Business (2019-2024)
11.11.5 SOTAX Recent Development
11.12 AMRI
11.12.1 AMRI Company Detail
11.12.2 AMRI Business Overview
11.12.3 AMRI Pharmaceutical Dissolution Testing Services Introduction
11.12.4 AMRI Revenue in Pharmaceutical Dissolution Testing Services Business (2019-2024)
11.12.5 AMRI Recent Development
11.13 SGS SA
11.13.1 SGS SA Company Detail
11.13.2 SGS SA Business Overview
11.13.3 SGS SA Pharmaceutical Dissolution Testing Services Introduction
11.13.4 SGS SA Revenue in Pharmaceutical Dissolution Testing Services Business (2019-2024)
11.13.5 SGS SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Intertek Group Plc.
Avivia BV
Almac Group
Agilent Technologies, Inc.
Catalent, Inc.
Thermofisher Scientific Inc.
Cambrex
Charles River Laboratories
Boston Analytical
Pace Analytical Life Sciences
SOTAX
AMRI
SGS SA

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂